UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 6, 2017 5:30 P.M.
Form:
S-4
CIK:
0001390478
Company Name:
Galena Biopharma, Inc.
File Number:
333-220592